Literature DB >> 18396135

PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response.

Bengt F Belgardt1, Andreas Husch, Eva Rother, Marianne B Ernst, F Thomas Wunderlich, Brigitte Hampel, Tim Klöckener, Dario Alessi, Peter Kloppenburg, Jens C Brüning.   

Abstract

Insulin- and leptin-stimulated phosphatidylinositol-3 kinase (PI3K) activation has been demonstrated to play a critical role in central control of energy homeostasis. To delineate the importance of pathways downstream of PI3K specifically in pro-opiomelanocortin (POMC) cell regulation, we have generated mice with selective inactivation of 3-phosphoinositide-dependent protein kinase 1 (PDK1) in POMC-expressing cells (PDK1(DeltaPOMC) mice). PDK1(DeltaPOMC) mice initially display hyperphagia, increased body weight, and impaired glucose metabolism caused by reduced hypothalamic POMC expression. On the other hand, PDK1(DeltaPOMC) mice exhibit progressive, severe hypocortisolism caused by loss of POMC-expressing corticotrophs in the pituitary. Expression of a dominant-negative mutant of FOXO1 specifically in POMC cells is sufficient to ameliorate positive energy balance in PDK1(DeltaPOMC) mice but cannot restore regular pituitary function. These results reveal important but differential roles for PDK1 signaling in hypothalamic and pituitary POMC cells in the control of energy homeostasis and stress response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396135     DOI: 10.1016/j.cmet.2008.01.006

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  67 in total

1.  Disruption of hypothalamic leptin signaling in mice leads to early-onset obesity, but physiological adaptations in mature animals stabilize adiposity levels.

Authors:  Laurence E Ring; Lori M Zeltser
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

2.  Phosphodiesterase-3B is expressed in proopiomelanocortin and neuropeptide Y neurons in the mouse hypothalamus.

Authors:  Maitrayee Sahu; David G Litvin; Abhiram Sahu
Journal:  Neurosci Lett       Date:  2011-10-06       Impact factor: 3.046

Review 3.  The role of FOXO in the regulation of metabolism.

Authors:  Danielle N Gross; Min Wan; Morris J Birnbaum
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

4.  A role of phosphodiesterase-3B pathway in mediating leptin action on proopiomelanocortin and neurotensin neurons in the hypothalamus.

Authors:  Abhiram Sahu
Journal:  Neurosci Lett       Date:  2010-05-13       Impact factor: 3.046

Review 5.  POMC Neurons: From Birth to Death.

Authors:  Chitoku Toda; Anna Santoro; Jung Dae Kim; Sabrina Diano
Journal:  Annu Rev Physiol       Date:  2017-02-10       Impact factor: 19.318

6.  Foxo1 Is Required for Normal Somatotrope Differentiation.

Authors:  Jyoti Kapali; Brock E Kabat; Kelly L Schmidt; Caitlin E Stallings; Mason Tippy; Deborah O Jung; Brian S Edwards; Leah B Nantie; Lori T Raeztman; Amy M Navratil; Buffy S Ellsworth
Journal:  Endocrinology       Date:  2016-09-15       Impact factor: 4.736

Review 7.  Hypothalamic inflammation in obesity and metabolic disease.

Authors:  Alexander Jais; Jens C Brüning
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

8.  Pdk1 activity controls proliferation, survival, and growth of developing pancreatic cells.

Authors:  Joby J Westmoreland; Qian Wang; Mohamed Bouzaffour; Suzanne J Baker; Beatriz Sosa-Pineda
Journal:  Dev Biol       Date:  2009-07-25       Impact factor: 3.582

Review 9.  Hormone and glucose signalling in POMC and AgRP neurons.

Authors:  Bengt F Belgardt; Tomoo Okamura; Jens C Brüning
Journal:  J Physiol       Date:  2009-09-21       Impact factor: 5.182

10.  Acute selective ablation of rat insulin promoter-expressing (RIPHER) neurons defines their orexigenic nature.

Authors:  Eva Rother; Bengt F Belgardt; Eva Tsaousidou; Brigitte Hampel; Ari Waisman; Martin G Myers; Jens C Brüning
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.